Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database, Lancet Oncol, vol.90, pp.278-88, 2016. ,
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases, Ann Surg, vol.230, pp.309-327 ,
Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies, Semin Surg Oncol, vol.22, pp.321-328, 1998. ,
Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases, Br J Surg, vol.90, pp.597-603, 200310. ,
A simple tumor load-based nomogram for surgery in patients with colorectal liver and peritoneal metastases, Ann Surg Oncol, vol.21, p.12, 2014. ,
Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus, Cancer Treat Rev, vol.41, p.13, 2015. ,
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis, Cancer Treat Res, vol.82, pp.359-74, 199614. ,
Reduction of peritoneal carcinomatosis by intraperitoneal administration of phospholipids in rats, Am J Pathol, vol.7, p.16, 2011. ,
Franquemont DW: Differentiation and risk assessment of gastrointestinal stromal tumors, J Invest Surg, vol.16, pp.99-102, 2003. ,
, Am J Clin Pathol, vol.103, pp.41-48, 199518.
Ultrasonic assessment of hepatic blood flow as a marker of mouse hepatocarcinoma, Ultrasound Med Biol, vol.33, pp.561-70, 200719. ,
Tumor and non-tumor liver angiogenesis is traced and evaluated by hepatic arterial ultrasound in murine models, Ultrasound Med Biol, vol.69, pp.1195-204, 200920. ,
al: Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial, REFERENCES 1. Nordlinger B, vol.184, pp.1007-1023, 2014. ,
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the openlabel, phase 3 TRIBE study, Lancet Oncol, vol.370, pp.1306-1321, 2007. ,
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database, Lancet Oncol, vol.17, pp.1709-1719, 2016. ,
Peritoneal carcinomatosis from colorectal cancer, Br J Surg, vol.89, pp.1545-50, 2002. ,
Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors, Br J Surg, vol.99, pp.364-371, 2012. ,
Peritoneal carcinomatosis from nongynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study, Cancer, vol.88, pp.358-63, 2000. ,
Natural history of patients with untreated liver metastases from colorectal cancer, Am J Surg, vol.141, pp.586-595, 198110. ,
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer, J Clin Oncol, vol.243, p.12, 2003. ,
Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy, Cancer, vol.92, p.13, 2001. ,
Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases, J Clin Oncol, vol.27, p.15, 1988. ,
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases, Ann Surg, vol.230, p.16, 1999. ,
,
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial, Lancet, vol.371, pp.1007-1023, 20082. ,
Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy, Cancer, vol.92, pp.71-77, 2001. ,
Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases, Br J Surg, vol.90, pp.567-74, 20034. ,
Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus, Cancer Treat Rev, vol.41, pp.729-770, 20155. ,
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival, Ann Surg, vol.240, pp.644-57, 20046. ,
Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases, Ann Surg, vol.240, pp.1052-61 ,
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study, Ann Surg Oncol, vol.18, pp.1306-1321, 2004. ,
Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study, Dis Colon Rectum, vol.54, pp.930-938, 201110. ,
Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy, Metastatic colorectal cancer: from improved survival to potential cure, vol.78, p.13, 2014. ,
Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer, Br J Surg, vol.89, p.15, 2012. ,
Peritoneal carcinomatosis from nongynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study, Cancer, vol.88, p.16, 2000. ,
Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors, Adv Cancer Res, vol.63, p.61, 1989. ,
Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-74, 201162. ,
Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review, Cancer Res, vol.49, p.63, 1989. ,
The recent progress of the mechanism and regulation of tumor necrosis in colorectal cancer, J Cancer Res Clin Oncol, vol.142, p.64, 2016. ,
Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression, Mac Gabhann F, Popel AS: Systems biology of vascular endothelial growth factors, vol.16, p.70, 1992. ,
Nicolson GL: Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites, Biochim Biophys Acta, vol.122, pp.175-224, 1966. ,
Ono M: Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy, The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis, vol.9, p.81, 2003. ,
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche, Nature, vol.438, p.82, 2005. ,
Cancer. A few to flip the angiogenic switch, Science, vol.319, pp.163-167, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-02055888
Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?, Nat Rev Cancer, vol.2, p.84, 2002. ,
A catalytic role for proangiogenic marrow-derived cells in tumor neovascularization, Cancer Cell, vol.13, p.85, 2008. ,
Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis, Nat Rev Mol Cell Biol, vol.319, p.88, 2004. ,
Partial hepatectomy in the mouse: technique and perioperative management, Michalopoulos GK, DeFrances MC: Liver regeneration, vol.16, pp.60-66, 1997. ,
Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis, Ann Surg, vol.206, p.91, 1987. ,
To divide or not to divide: revisiting liver regeneration, Cell Div, vol.8, issue.8, 201392. ,
Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice, Proc Natl Acad Sci U S A, vol.99, p.93, 2002. ,
Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration, Hepatology, vol.468, p.95, 1999. ,
Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver, Hepatology, vol.34, p.96, 2001. ,
Expression of hypoxia inducible factor-1alpha during liver regeneration induced by partial hepatectomy in rats, Liver Int, vol.25, pp.1002-1011, 200597. ,
Shear stress-induced nitric oxide release triggers the liver regeneration cascade, Nitric Oxide, vol.5, p.98, 2001. ,
Dvorak HF: Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy, J Histochem Cytochem, vol.49, pp.4368-80, 2001. ,
, Vascular endothelial growth factor, vol.34, pp.683-692, 2001.
Vascular endothelial growth factor increases fenestral permeability in hepatic sinusoidal endothelial cells, Liver Int, vol.23, pp.467-75, 2003. ,
Sinusoidal endothelial cell proliferation and expression of angiopoietin/Tie family in regenerating rat liver, Hepatology, vol.34, pp.141-149, 2000. ,
Hepatic ischemia-reperfusion increases circulating bone marrow-derived progenitor cells and tumor growth in a mouse model of colorectal liver metastases, J Surg Res, vol.184, pp.888-97, 2013. ,
, Fausto N: Liver regeneration, J Hepatol, vol.32, pp.19-31, 2000.
Serial changes of cytokines and growth factors in peripheral circulation after right lobe donor hepatectomy, Involvement of the innate immune system in liver regeneration and injury, vol.9, pp.344-51, 1995. ,
, J Hepatol, vol.45, pp.347-356, 2006.
Hepatocyte growth factor is an invasion/migration factor of rat urothelial carcinoma cells in vitro, Carcinogenesis, vol.20, pp.957-62, 1999. ,
Hepatocyte growth factor in lung morphogenesis and tumor invasion: role as a mediator in epithelium-mesenchyme and tumorstroma interactions, Cancer Chemother Pharmacol, vol.38, pp.1379-83, 1996. ,
Paradoxical effects of short-and long-term interleukin-6 exposure on liver injury and repair, Hepatology, vol.43, pp.474-84, 2006. ,
Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer?, Cancer Treat Rev, vol.39, pp.610-618, 2012. ,
Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor, Proc Natl Acad Sci U S A, vol.94, pp.1441-1447, 1997. ,
Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy, Am J Physiol, vol.263, pp.579-85, 1992. ,
Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases, Cell Biol Int Rep, vol.141, pp.865-73, 1989. ,
Influence of postoperative morbidity on longterm survival following liver resection for colorectal metastases, Gastroenterology, vol.90, pp.1296-310, 2008. ,
The Influence of Liver Resection on Intrahepatic Tumor Growth, J Vis Exp, vol.53946, 2016. ,
Liver regeneration stimulates tumor metastases, J Surg Res, vol.138, pp.284-90, 2007. ,
Thermoablation of colorectal liver metastases promotes proliferation of residual intrahepatic neoplastic cells, Br J Cancer, vol.65, pp.882-889, 1992. ,
During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma, Br J Surg, vol.86, pp.784-792, 1999. ,
,
, J Chir (Paris), vol.144, pp.275-281, 2007.
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis, Cancer Treat Res, vol.82, pp.359-74, 1996. ,
Reduction of peritoneal carcinomatosis by intraperitoneal administration of phospholipids in rats, Am J Pathol, vol.7, pp.1861-1870, 2011. ,
Surgical Treatment of Colorectal Cancer with Peritoneal and Liver Metastases Using Combined Liver and Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Report from a Single-Centre Experience, Eur J Surg Oncol, vol.43, pp.666-673, 2016. ,
New Perspectives in the Treatment of Colorectal Metastases, Liver Cancer, vol.6, pp.90-98, 2016. ,
Multidisciplinary Treatment for Colorectal Peritoneal Metastases: Review of the Literature, Gastroenterol Res Pract, p.1516259, 2016. ,
Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre, ANZ J Surg, 2015. ,
Surgical management of colorectal peritoneal metastases: treatment and outcomes compared with hepatic metastases, J Gastrointest Cancer, vol.40, pp.170-176, 2013. ,
Outcomes associated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in colorectal cancer patients with peritoneal surface disease and hepatic metastases, Lancet Oncol, vol.115, pp.461-467, 2008. ,
Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review, Expert Rev Gastroenterol Hepatol, vol.11, pp.1373-80, 2003. ,
Christophi C, Harun N, Fifis T: Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors, J Gastrointest Surg, vol.48, pp.966-80, 2008. ,
Liver surgery induces an immediate mobilization of progenitor cells in liver cancer patients: A potential role for G-CSF, Cancer Biol Ther, vol.9, pp.743-751, 2010. ,
Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin, Nat Rev Gastroenterol Hepatol, vol.10, pp.1792-800, 2013. ,
Intraperitoneal Vascular Endothelial Growth Factor: A Prognostic Factor and the Potential for Intraperitoneal Bevacizumab Use in Peritoneal Surface Malignancies, Ann Surg Oncol, vol.22, pp.880-887, 2015. ,
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors, J Exp Med, vol.212, pp.139-187, 2015. ,
Control of the immune response by proangiogenic factors, Front Oncol, vol.4, 2014. ,
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer, J Clin Oncol, vol.260, pp.3737-3743, 2003. ,
A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin, Ann Surg Oncol, vol.16, pp.2152-2165, 2009. ,
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study, J Clin Oncol, vol.22, pp.3284-3292, 2004. ,
Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures, Ann Surg Oncol, vol.10, pp.863-869, 2003. ,
, Présentation du rapport de l'AFC. In: Arnette ED (ed) Carcinoses péritonéales d'origine digestive et primitive. Association Française de chirurgie, p.680, 2008.
, Surg Endosc, vol.30, p.3813, 2016.
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg, vol.240, pp.205-213, 2004. ,
Laparoscopy in the management of peritoneal carcinomatosis, Cancer J, vol.15, issue.3, pp.190-195, 2009. ,
Elective surgery in recurrent colon cancer with peritoneal seeding: when to and when not to proceed, G Chir, vol.20, pp.81-86, 1999. ,
, Surg Endosc, vol.30, pp.3808-3815, 2016.
,
, Claudius Regaud Institute IUTC
,
,
,
,
, Peggy Dartigues
,
,
, ICO René Gauducheau Cancer Center
,
,
,
,
,
, Marie Faruch-Bilfeld
, Claudius Regaud Institute IUTC
,
MD (Department of Radiology, ICO René Gauducheau Cancer Center ,
,
,
,
, Aymeric Guibal, MD (Department of Radiology, Hospital of Perpignan
,
,
,
,
, ICO René Gauducheau Cancer Center
MD (Department of Radiology, Francois Baclesse Comprehensive Cancer Center ,
, Gerlinde Lang-Averous
,
,
, Multicenter Study S743
, Hospital
,
MD (Department of Surgery, Léon Bérard Comprehensive Cancer Center ,
, Claudius Regaud Institute IUTC
,
, Mother and Child Pole
,
,
,
,
MD (Department of Pathology, Francois Baclesse Comprehensive Cancer Center ,
,
,
,
, Hospital Saint-Antoine AP-HP
,
,
MD (Department of Radiology ,
,
, ICO Paul Papin Cancer Center
Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study, Cancer, vol.88, issue.2, pp.358-63, 2000. ,
Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer, Sem Oncol, vol.16, issue.4, pp.83-97, 1989. ,
Intra-Peritoneal Chemo-Hyperthermia (CHIP): a new therapy in the treatment of the peritoneal seedings, Int Surg, vol.76, issue.3, pp.164-171, 1991. ,
Early-and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, J Clin Oncol, vol.30, issue.20, pp.2449-56, 2012. ,
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience, J Clin Oncol, vol.27, issue.36, pp.6237-6279, 2009. ,
Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?, Ann Surg, vol.257, issue.6, pp.1065-71, 2013. ,
Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility?, Ann Surg Oncol, 2016. ,
The coming acceleration of global population ageing, Nature, vol.451, issue.7179, pp.716-725, 2008. ,
Major cancer surgery in the elderly: results from the American College of Surgeons National Surgical Quality Improvement Program, Ann Surg, vol.251, issue.2, pp.311-319, 2010. ,
Liver resection of colorectal metastases in elderly patients ,
, Br J Surg, vol.97, issue.3, pp.366-76, 2010.
Prediction of postoperative complications in elderly patients with hepatocellular carcinoma, J Surg Res, vol.185, issue.2, pp.614-623, 2013. ,
The safety of a pancreaticoduodenectomy in patients older than 80 years: risk vs. benefits, HPB, vol.14, issue.9, pp.583-591, 2012. ,
Pancreaticoduodenectomy in elderly adults: is it justified in terms of mortality, long-term morbidity, and quality of life?, J Am Geriatrics Soc, vol.61, issue.8, pp.1351-1358, 2013. ,
The impact of old age on surgical outcomes of totally laparoscopic gastrectomy for gastric cancer, Surg Endosc, vol.27, issue.11, pp.3990-3997, 2013. ,
Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis, J Surg Oncol, vol.110, issue.5, pp.575-84, 2014. ,
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in elderly patients, In vivo, vol.25, issue.4, pp.687-90, 2011. ,
Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis, J Surg Oncol, vol.105, issue.2, pp.113-121, 2012. ,
Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly, Surg Oncol, vol.22, issue.3, pp.184-193, 2013. ,
,
Outcomes of Cytoreductive Surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality, Ann Surg Oncol, vol.20, issue.11, pp.3497-503, 2013. ,
Cytoreductive surgery and HIPEC for peritoneal carcinomatosis in the elderly, Int J Surg Oncol, p.987475, 2014. ,
Cytoreduction and HIPEC after neoadjuvant chemotherapy in stage IIIC-IV ovarian cancer ,
, Eur J Obst Gynecol Reprod Biol, vol.179, pp.88-93, 2014.
Hyperthermic intraperitoneal chemotherapy for the treatment of recurrent ovarian cancer in elderly women, Acta Obstet Gynecol Scand, vol.94, issue.4, pp.435-444, 2015. ,
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly, World J Surg Oncol, vol.13, p.262, 2015. ,
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Peritoneal carcinomatosis: principles of management, Cancer Treatment Res, vol.82, pp.359-74, 1996. ,
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement, Ann Surg Oncol, vol.14, issue.1, pp.128-161, 2007. ,
, Cancer Therapy Evaluation Program. Common terminology criteria for adverse events v3.0 (CTCAE), 2013.
Peritonectomy procedures. Cancer treatment and research, vol.134, pp.247-64, 2007. ,
Management and survival of colorectal cancer in the elderly in populationbased studies, Eur J Cancer, vol.43, issue.15, pp.2279-84, 1990. ,
Role of age on the outcome of liver surgery. A single institution experience, Surg Practice, vol.13, issue.2, pp.32-37, 2009. ,
Impact of age on perioperative complications and length of stay in patients undergoing noncardiac surgery, Ann Intern Med, vol.134, issue.8, pp.637-680, 2001. ,
Establishing standards of quality for elderly patients undergoing pancreatic resection, Arch Surg, vol.144, issue.10, pp.950-956, 1960. ,
Rectal cancer surgery in patients more than 80 years of age, Am J Surg, vol.185, issue.1, pp.54-61, 2003. ,
Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials, Ann Surg Oncol, vol.11, issue.5, pp.518-539, 2004. ,
Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality, Ann Surg, vol.249, issue.6, pp.900-907, 2009. ,
Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis, Ann Surg Oncol, vol.10, issue.2, pp.155-62, 2003. ,
Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin, Ann Surg Oncol, vol.15, issue.1, pp.125-158, 2008. ,
, A Case-Controlled, Multicenter Study S745
Appendiceal neoplasms and pseudomyxoma peritonei: a population based study, Eur J Surg Oncol, vol.34, pp.196-201, 2008. ,
, World J Gastrointest Oncol, vol.2, pp.44-50, 2010.
New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?, Lancet Oncol, vol.7, pp.69-76, 2006. ,
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis, Cancer Treat Res, vol.82, pp.359-74, 1996. ,
Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases, J Clin Pathol, vol.65, pp.919-942, 2012. ,
The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), Eur J Surg Oncol, vol.41, pp.1097-105, 2015. ,
Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4), World J Surg Oncol, vol.6, p.118, 2008. ,
Successful antiangiogenic combination therapy for pseudomyxoma peritonei with bevacizumab and capecitabine, Cancer Biol Ther, vol.8, pp.1459-62, 2009. ,
Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy, Ann Surg, vol.241, pp.300-308, 2005. ,
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur J Cancer, vol.45, pp.228-275, 2009. ,
Anti-TNFalpha therapy early improves hemodynamics in local intestinal and extraintestinal circulations in active Crohn's disease, J Crohns Colitis, vol.7, pp.451-460, 2013. ,
Angiotensinogen delays angiogenesis and tumor growth of hepatocarcinoma in transgenic mice, Cancer Res, vol.69, pp.2853-60, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00595860
Preclinical assessment of the efficacy of anti-angiogenic therapies in hepatocellular carcinoma, Ultrasound Med Biol, vol.42, pp.438-484, 2016. ,
Ultrasonic assessment of hepatic blood flow as a marker of mouse hepatocarcinoma, Ultrasound Med Biol, vol.33, pp.561-70, 2007. ,
Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling, J Hepatol, vol.55, pp.866-75, 2011. ,
Orthotopic animal model of pseudomyxoma peritonei: an in vivo model to test anti-angiogenic drug effects, Am J Pathol, vol.184, pp.1920-1929, 2014. ,
Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy ,
, Ann Surg, vol.221, pp.124-156, 1995.
, British Standards Institution. Precision of test method (BS5497, part 1). London: BSI, 1979.
Human anatomy and physiology, Cardiovascular system: blood vessels, pp.849-80, 2014. ,
Pseudomyxoma peritonei: role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction, Eur J Surg Oncol, vol.36, pp.315-338, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00566743
Mucinous appendiceal neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings, AJR Am J Roentgenol, vol.190, pp.656-65, 2008. ,
Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei, Hum Pathol, vol.54, pp.47-54, 2016. ,
Surveillance MR imaging is superior to serum tumor markers for detecting early tumor recurrence in patients with appendiceal cancer treated with surgical cytoreduction and HI-PEC, Ann Surg Oncol, vol.20, pp.1074-81, 2013. ,
, , pp.1-7, 2017.
Prediction of clinical outcome using blood flow volume in the superior mesenteric artery in patients with pseudomyxoma peritonei treated by cytoreductive surgery, Eur J Surg Oncol, 2017. ,
, Neoadjuvant bidirectional chemotherapy combining intraperitoneal Docetaxel with intravenous 5-fluorouracil and oxaliplatin for patients with non-resectable peritoneal carcinomatosis from gastric cancer: the first pilot study in Western countries Running head: Neoadjuvant bidirectional chemotherapy for peritoneal carcinomatosis from gastric cancer Authors
PhD 5 , Marc POCARD, MD, PhD 1,2 Affiliations : 1 Service de Chirurgie Digestive et Cancérologique, Hôpital Lariboisière, Carcinose Angiogenèse et Recherche Translationnelle (CART), vol.5 ,
, 5 Service HEpato-Gastroenterologie et Oncologie Digestive, Hôpital Européen Georges Pompidou
, AP-HP
, Carcinose Angiogenèse et Recherche Translationnelle (CART)
,
Data and statistical analysis and interpretation: Rea LO DICO, Marc POCARD Drafting and editing of manuscript: All authors Critical manuscript review and approval of final version: All authors in Japan in terms of epidemiology and clinical response to the surgery, rea.lo-dico@aphp.fr Conflicts of interest: None to declare Sources of support: No funding -No financial relationships ,
, We planned a novel therapeutic strategy for Western Country combining administration of IP docetaxel with IV FOLFOX-4 (5-fluorouracil and oxaliplatin) in patients with non-resectable PC from gastric cancer in order to facilitate the setup of a phase I trial. The main endpoint of our pilot study was evaluated the feasibility and safety of this neoadjuvant bidirectional treatement, More, the oral S-1 is considered as inefficient on European Caucasian patient and is not delivered in Europe
, Chemotherapy for advanced gastric cancer, 2010.
, , 2014.
Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia, Lancet Oncol, vol.5, pp.219-247, 2004. ,
Gynecologic Oncology Group. Intraperitoneal cisplatin and paclitaxel in ovarian cancer, N Engl J Med, vol.354, issue.1, pp.34-43, 2006. ,
Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer, Arch Surg, vol.139, pp.20-26, 2004. ,
Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination, Surgery, vol.119, pp.437-481, 1996. ,
Neoadjuvant treatment of gastric cancer with peritoneal dissemination -EJSO, vol.32, pp.661-665, 2006. ,
Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery, J Surg Oncol, vol.100, issue.4, pp.311-317, 2009. ,
Indication for oophorectomy during cytoreduction for intraperitoneal metastatic spread of colorectal or appendiceal origin, Br J Surg, vol.98, pp.287-92, 2011. ,
Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations, Ann Oncol, vol.22, issue.10, pp.2179-2190, 2011. ,
Single-incision flexible endoscopy (SIFE) for detection and staging of peritoneal carcinomatosis, Surg Endosc, vol.30, issue.9, pp.3808-3823, 2016. ,
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis, Cancer Treat Res, vol.82, pp.359-74, 1996. ,
, The "Hammock, vol.5, pp.24-30, 2012.
, Common Terminology Criteria for Adverse Event
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg, vol.240, pp.205-218, 2004. ,
, , 2000.
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world, J Clin Oncol, vol.24, pp.2137-50, 2006. ,
, Glehen J Clin Oncol, vol.19, 2004.
8-Year follow-up of randomized trial:cytoreduction and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer, Ann Surg Oncol, vol.15, pp.2633-2638, 2008. ,
, , 2010.
Peritoneal carcinomatosis from gastric cancer: A multiinstitutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy ,
URL : https://hal.archives-ouvertes.fr/hal-02303675
, Ann Surg Oncol, p.25, 2010.
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer, N Engl J Med, vol.355, pp.11-20, 2006. ,
Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement, Curr Oncol, vol.21, pp.129-136 ,
Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma, J Clin Oncol, vol.27, pp.3465-71, 2009. ,
, Ishigami et al.Phase II study, Yonemura J Clin Oncol, vol.27, pp.67-70, 2009.
Impact of intraperitoneal chemotherapy after gastrectomy with positive cytological findings in peritoneal washings, Eur Surg Res, vol.47, issue.4, pp.254-263, 2011. ,
Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination, J Surg Oncol, vol.105, issue.1, pp.38-42, 2012. ,
Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis, Cancer Chemother Pharmacol, vol.71, pp.1256-72, 2013. ,
A phase 2 trialCancer, vol.119, pp.3354-3362, 2013. ,
Peritoneal Carcinomatosis: Principles of Management, pp.53-63, 1996. ,
, Dedrick Cancer chemother Pharmacol, 1978.
, Minchiton Nat Rev Cancer, 2006.
, Flessner Am j physiol, vol.36, 1985.
Phase I trial of intraperitoneal Docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacology, Clin Cancer Res, vol.9, pp.5896-901, 2003. ,
, Fujiwara Anticancer Res, 2010.
, , 2009.
Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer, World J Gastrointetinal Oncol, vol.2, pp.85-97, 2010. ,
Laparoscopic staging of peritoneal surface malignancies, Eur J Surg Oncol, vol.32, pp.625-632, 2006. ,